Rapid Commercialization: How to use AI to 10x Post-Approval Enablement

January 23rd at 12PM ET


Today, getting a drug to market can be as hard as creating it. From scaling manufacturing to FDA approval, it's a years-long process.


Post-approval, teams often need to reach thousands of reps and stakeholders globally. Even more challenging, it can take months to build and deliver enablement.


Meet your new post-approval enablement process — Arist's AI turns any piece of content (PDF, Word, PPTX etc.) into a course instantly and pushes it where reps already are via SMS, MS Teams, Slack, and WhatsApp.


The result: 10x speed to program execution -> 90% adoption and completion -> stakeholders and reps fully trained


In this conversation, we'll discuss:

  • Challenges to post-approval enablement today

  • How to use AI thoughtfully to enhance this process

  • How your team can reduce enablement time by 90% today

Bring

real impact

to your people

We care about solving meaningful problems and being thought partners first and foremost. Arist is used and loved by the Fortune 500 — and we'd love to support your goals.


Curious to get a demo or free trial? We'd love to chat:

Build skills and shift behavior at scale, one behavioral touchpoint at a time.

(617) 468-7900

support@arist.co

2261 Market Street #4320
San Fransisco, CA 94114

Subscribe to Arist Bites:

Built and designed by Arist team members across the United States.


Copyright 2024, All Rights Reserved.

Build skills and shift behavior at scale, one behavioral touchpoint at a time.

(617) 468-7900

support@arist.co

2261 Market Street #4320
San Francisco, CA 94114

Subscribe to Arist Bites:

Built and designed by Arist team members across the United States.


Copyright 2024, All Rights Reserved.

Build skills and shift behavior at scale, one behavioral touchpoint at a time.

(617) 468-7900

support@arist.co

2261 Market Street #4320
San Fransisco, CA 94114

Subscribe to Arist Bites:

Built and designed by Arist team members across the United States.


Copyright 2024, All Rights Reserved.